November 10, 2026 at 10:17 PM UTC
8-K - Acrivon Therapeutics, Inc. (0001781174) (Filer)
Filed: 2026-11-10 AccNo: 0001193125-26-455669 Size: 13 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Official source: U.S. Securities and Exchange Commission
Official source published: November 10, 2026 at 09:55 PM UTC
Open official source